Delivery Order SPE2DB22D2006-SPE2DB24FV9YU
- Not listed
- The federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA). The Firm Fixed Price delivery order, valued at $4,701.81, has an ultimate completion date of March 1, 2024. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables...
- This federal contract award, valued at $11,679.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Advair HFA 230-21 MCG inhalers, a pharmaceutical product used for the treatment of respiratory conditions. This is a firm-fixed-price delivery order contract with a completion date of February 13, 2024. The contract was awarded on an open competition basis, with no set-aside designations....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $13,505.54 and an ultimate completion date of January 26, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award was made without a set-aside designation, indicating open competition....
- This federal contract award, valued at $17,822.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler, a pharmaceutical product, with a completion date of May 7, 2024. The contract type is a Delivery Order, with a Firm Fixed Price pricing mechanism. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has a...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Advair HFA 230-21 MCG Inhaler 12GM. The $21,793.70 firm fixed price delivery order has a completion date of February 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Advair HFA 230-21 MCG inhalers. The firm-fixed-price delivery order, valued at $15,070.88, has an ultimate completion date of April 3, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 115-21 mcg inhalers. The $25,074.96 firm fixed-price delivery order contract has a completion date of May 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award is a delivery order worth $7,315.86 issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The award is for the delivery of Advair HFA 115-21 mcg inhalers, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 26, 2024 and is a firm fixed-price delivery order. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Advair HFA 230-21 MCG Inhaler 12GM. The contract has a ceiling value of $16,536.57 and an ultimate completion date of March 11, 2024. The contract is a Delivery Order and uses a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Advair HFA 115-21 MCG Inhaler 12GM. The $4,571.62 firm fixed-price delivery order has an ultimate completion date of January 4, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV9YUDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $20,165.89 for Advair HFA 230-21 MCG Inhaler 12GM. The contract is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The ultimate completion date is May 1, 2024. This award is not associated with a set-aside program and was competed openly. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999.00, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000.00, to provide a wide range of pharmaceutical products and medical supplies to support military, veterans, and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.2k | 4/30/24 |